The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years of Age or More at Risk of Losing Their Independance.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- Assessing quality of life in Parkinson's disease by PDQ8 questionnaires
研究概览
简要总结
There is no cure for Parkinson's disease, resulting in an interest for research in this domain. Non pharmacological measures remain essential, specifically physical activity. Hippotherapy is a nonconventional method which uses the horse in addition to standard care. The goal being to improve or maintain the gains of the person through cognitive, sensorial and motor stimulation, with the aim of improving quality of life and maintaining independence. With this in mind, the researchers propose to evaluate quality of life as the main criterion, using the PDQ8 scale validated for this disease. The researchers hope results will lead to the coverage of the costs of non-conventional therapies such as hippotherapy by social security services.
详细描述
Parkinson's disease is a degenerative disorder with a prevalence of 2.50 patients per 1,000 people in 2015. Prevalence and incidence increase progressively with age up to the age of 80; more than half of patients are over 75.
There are two main types of Parkinson's disease in the elderly:
- Parkinson's disease begins late, after the age of 75, and the disease may progress relatively slowly if there are no co-morbidities.
- Or Parkinson's disease has been evolving for a long time, starting on average around the age of 55, and in this situation a number of difficulties arise depending on how long the disease has been present, the association of motor and non-motor fluctuations, the emergence of axonal signs and a decline in the severity of the disease, signs and a decline in cognitive function.
The therapeutic management of Parkinson's disease in the elderly must be assessed on a case-by-case basis. The efficacy/tolerance ratio of dopaminergic treatments must be taken into account.
In Alzheimer's disease (AD), it has been shown that aerobic exercise can delay cognitive decline. With this in mind, the researchers would like to propose a new and original approach using equitherapy in elderly Parkinson's patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 75 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥ 75 years with PD according to Movement Disorders Society criteria (2015).
- •Clinical diagnosis of Alzheimer's disease
- •Has been on stable antiparkinsonian treatment for less than 3 months.
- •Ability to understand the principle of the study as well as its risks.
- •Written consent to participate in the trial.
- •Have social insurance
- •Agree to comply with all safety procedures during the study and its duration.
- •Ability to understand and freely give consent
- •Patient affiliated to social security or entitled beneficiary
- •Autonomy preserved
排除标准
- •age <75 years
- •refusal to sign consent
- •MOCA <23
- •Presence of major behavioural problems that do not allow MRI to be performed under optimal conditions
- •Subjects unable to receive informed information, unable to participate in the study as a whole
- •Subjects with a diagnosis of atypical parkinsonian syndrome (Lewy body disease, progressive supranuclear palsy, multisystem atrophy, cortico-basal degeneration, etc.).
- •A classic contraindication to an MRI examination: claustrophobia, presence of incompatible foreign material,
- •Subjects who have practised horse riding at a high level, animal phobias, wish to stop studying, etc.
- •No affiliation to a social security scheme
- •Antiparkinsonian treatment has not been stable for at least 3 months.
- •People under protective supervision (guardianship, curatorship)
- •People under family guardianship are also excluded, as are people for whom a mandate for future protection has been activated.
研究组 & 干预措施
hippotherapy sessions
Patients will benefit from the hippotherapy sessions in additional to continuing to receive traditional care ,To evaluate any differences between the initial visit and the evaluation following 6 weeks in PDQ8 scores, which contain 8 items given a score between 0 (never) and 4 (always)
干预措施: hippotherapy sessions (Other)
结局指标
主要结局
Assessing quality of life in Parkinson's disease by PDQ8 questionnaires
时间窗: 06 weeks
changes from baseline in PDQ8 scores, which contain 8 items given a score between 0 (never) and 4 (always) maximum control; range, 0 to 32.
次要结局
- Assessing Parkinson's disease Postural and walking disorders(06 weeks)
- Assessing Parkinson's disease severity of the non-motor symptoms(06 weeks)
- MRI in diagnosis differential in Parkinson's disease(day 0)
- Assessing Parkinson's disease Motor disorders(06 weeks)